Different local control depending on the type of cancer results from different tumour biology (e.g., RAS and p53 mutations are considered to increase radioresistance), different sensitivity to radiation expressed by the alpha/beta ratio, possibilities of systemic treatment and the natural history of the cancer [37,38]. This evidence concerns the gene TP53 and cancer.